Muhieddine Labban

847 total citations
68 papers, 389 citations indexed

About

Muhieddine Labban is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Muhieddine Labban has authored 68 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 20 papers in Surgery. Recurrent topics in Muhieddine Labban's work include Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (12 papers) and Global Cancer Incidence and Screening (11 papers). Muhieddine Labban is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (25 papers), Prostate Cancer Treatment and Research (12 papers) and Global Cancer Incidence and Screening (11 papers). Muhieddine Labban collaborates with scholars based in United States, Lebanon and Germany. Muhieddine Labban's co-authors include Quoc‐Dien Trinh, Albert El Hajj, Nassib Abou Heidar, Alexander P. Cole, Stuart R. Lipsitz, Rami Nasr, Adam S. Kibel, David‐Dan Nguyen, Nicola Frego and Logan Briggs and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Muhieddine Labban

62 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhieddine Labban United States 10 200 103 101 51 48 68 389
Martin Nuttall United Kingdom 8 202 1.0× 153 1.5× 71 0.7× 58 1.1× 33 0.7× 13 423
Daniel Pucheril United States 11 250 1.3× 149 1.4× 86 0.9× 143 2.8× 59 1.2× 39 472
Kristen McAlpine Canada 10 113 0.6× 85 0.8× 41 0.4× 36 0.7× 30 0.6× 44 317
Dane Klett United States 10 167 0.8× 152 1.5× 60 0.6× 49 1.0× 22 0.5× 31 369
Tudor Borza United States 13 100 0.5× 217 2.1× 51 0.5× 56 1.1× 13 0.3× 39 438
Brian Little United Kingdom 10 118 0.6× 67 0.7× 27 0.3× 39 0.8× 73 1.5× 20 309
Benjamin A. Sherer United States 13 290 1.4× 117 1.1× 25 0.2× 56 1.1× 137 2.9× 32 475
Moben Mirza United States 12 89 0.4× 193 1.9× 109 1.1× 48 0.9× 12 0.3× 42 448
Vishnu Ganesan United States 13 197 1.0× 103 1.0× 48 0.5× 42 0.8× 88 1.8× 28 368
Richard Brough United Kingdom 10 127 0.6× 111 1.1× 48 0.5× 60 1.2× 26 0.5× 23 287

Countries citing papers authored by Muhieddine Labban

Since Specialization
Citations

This map shows the geographic impact of Muhieddine Labban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhieddine Labban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhieddine Labban more than expected).

Fields of papers citing papers by Muhieddine Labban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhieddine Labban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhieddine Labban. The network helps show where Muhieddine Labban may publish in the future.

Co-authorship network of co-authors of Muhieddine Labban

This figure shows the co-authorship network connecting the top 25 collaborators of Muhieddine Labban. A scholar is included among the top collaborators of Muhieddine Labban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhieddine Labban. Muhieddine Labban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Labban, Muhieddine, Stuart R. Lipsitz, Sascha Ahyai, et al.. (2025). Carbon Emissions From Patient Travel for Health Care. JAMA Network Open. 8(3). e252513–e252513. 6 indexed citations
2.
3.
4.
Gerstl, Jakob V. E., et al.. (2025). The utility of the 5-Item frailty index in assessing the risk of complications and mortality following surgical management of non-traumatic subarachnoid hemorrhage. Journal of Clinical Neuroscience. 134. 111111–111111. 1 indexed citations
5.
Briggs, Logan, Benjamin V. Stone, Muhieddine Labban, et al.. (2024). The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey. Prostate International. 12(4). 207–212. 2 indexed citations
6.
Stone, Benjamin V., Muhieddine Labban, Stuart R. Lipsitz, et al.. (2024). Socioeconomic determinants of cancer screening adherence among cancer survivors: analysis from the 2020 Behavioral Risk Factor Surveillance System. JNCI Cancer Spectrum. 9(1). 2 indexed citations
7.
Labban, Muhieddine, Stephan Korn, Nicolò Maria Buffi, et al.. (2024). Investigating the pattern of prostate specific antigen screening among E-cigarette smokers within the behavioral risk factor surveillance system. Urologic Oncology Seminars and Original Investigations. 43(4). 272.e1–272.e9. 2 indexed citations
8.
Stone, Benjamin V., Muhieddine Labban, Nicola Frego, et al.. (2023). Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National Survey. Urology Practice. 10(5). 459–466. 6 indexed citations
9.
10.
Briggs, Logan, Muhieddine Labban, David‐Dan Nguyen, et al.. (2023). Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review. JCO Oncology Practice. 19(5). e784–e793. 7 indexed citations
11.
Marks, Phillip, Muhieddine Labban, Benjamin V. Stone, et al.. (2023). The national utilization of nonoperative management for small renal masses over 10 years. JNCI Cancer Spectrum. 7(6). 2 indexed citations
12.
Labban, Muhieddine, Nicola Frego, Stephen W. Reese, et al.. (2023). Institutional trends and safety profile of same-day discharge for robot-assisted laparoscopic radical prostatectomy: A retrospective analysis. Urologic Oncology Seminars and Original Investigations. 41(8). 354.e19–354.e26. 5 indexed citations
13.
Friedlander, David F., Muhieddine Labban, Mark A. Preston, et al.. (2023). Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.. PubMed. 30(6). 11714–11723. 1 indexed citations
14.
Hajj, Albert El, et al.. (2022). Learning curve in aquablation: an international multicenter study. World Journal of Urology. 40(3). 773–779. 9 indexed citations
15.
Tan, Wei Shen, Nicholas Campain, Alexander P. Cole, et al.. (2022). Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy. European Urology Focus. 9(2). 333–335. 1 indexed citations
16.
Labban, Muhieddine, Logan Briggs, Alexander P. Cole, & Quoc‐Dien Trinh. (2021). Measuring What Matters: Patient-Reported Outcome and Experience Measures for Men Undergoing Radical Prostatectomy. European Urology Focus. 7(5). 913–915. 6 indexed citations
17.
Labban, Muhieddine, et al.. (2021). Perioperative Outcomes of Anatomic Endoscopic Enucleation of the Prostate, Robotic and Open Simple Prostatectomy From a Multi-Institutional Database. SHILAP Revista de lepidopterología. 2(4). 196–209. 1 indexed citations
18.
Shahait, Mohammed, Muhieddine Labban, Ryan W. Dobbs, et al.. (2020). A 5-Item Frailty Index for Predicting Morbidity and Mortality After Radical Prostatectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database. Journal of Endourology. 35(4). 483–489. 31 indexed citations
19.
Labban, Muhieddine, et al.. (2020). The role of cautery in Aquablation for benign prostatic obstruction: Is it imperative? A single tertiary center experience. European Urology Open Science. 19. e380–e380.
20.
Heidar, Nassib Abou, et al.. (2019). Inflammatory serum markers predicting spontaneous ureteral stone passage. Clinical and Experimental Nephrology. 24(3). 277–283. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Nuttall Breakdown of academic impact, for papers by Daniel Pucheril Breakdown of academic impact, for papers by Kristen McAlpine Breakdown of academic impact, for papers by Dane Klett Breakdown of academic impact, for papers by Tudor Borza Breakdown of academic impact, for papers by Brian Little Breakdown of academic impact, for papers by Benjamin A. Sherer Breakdown of academic impact, for papers by Moben Mirza Breakdown of academic impact, for papers by Vishnu Ganesan Breakdown of academic impact, for papers by Richard Brough
Rankless by CCL
2026